Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_assertion type Assertion NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_head.
- NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_assertion description "[This article provides an overview on the biological pathways and biomarkers, including EGFR, KRAS, BRAF, ALK, ROS1, HER2, and KIT for targeted treatment of lung, gastrointestinal, colorectal, and breast cancers as well as malignant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_provenance.
- NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_assertion evidence source_evidence_literature NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_provenance.
- NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_assertion SIO_000772 23574530 NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_provenance.
- NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_assertion wasDerivedFrom befree-20140225 NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_provenance.
- NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_assertion wasGeneratedBy ECO_0000203 NP213451.RAd-1U0BZj3_pWhDNlGs32i71rEmXFwdo3O-L-TB8BrfU130_provenance.